Patents by Inventor John Monn

John Monn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bis-benzazoles and their use as antineoplastic agents
    Patent number: 6589971
    Abstract: “Head-to-head” bis-benzimidazoles having the following formula wherein A1, A2, X1 and X2 are as defined in the following specification, have been found to bind to specific sequences in the minor groove of duplex DNA, and to have cytotoxic effects against a range of tumor cell lines.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: July 8, 2003
    Assignees: The Queens University of Belfast, Institute of Cancer Research, The University of Reading
    Inventors: Stephen Neidle, John Monn